胆固醇对瘤免疫微环境的影响:从基本概念到机制和影响
Francisco Alejandro Lagunas-Rangel1,2
1Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Frontiers in oncology
|April 24, 2025
概括
胆固醇在瘤微环境中的积累推动了癌症的生长,并抑制了免疫反应. 准胆固醇代谢提供了一个有希望的策略,以加强癌症治疗,特别是免疫检查点封锁.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢研究研究 代谢研究
背景情况:
- 瘤微环境 (TME) 的特点是从癌细胞生物合成和吸收中丰富胆固醇.
- 累积的胆固醇及其代谢物起到不同的作用,包括在TME中提供能量和抑制免疫力.
研究的目的:
- 审查胆固醇对瘤免疫场景的影响的分子机制.
- 探索降胆固醇药物在增强抗瘤免疫反应和提高癌症治疗疗效方面的潜力.
主要方法:
- 文献综述和现有关于癌症中胆固醇代谢的研究的综合.
- 分析胆固醇及其副产品在TME内的免疫细胞动态中的功能作用.
主要成果:
- 胆固醇的积累支持瘤生长,并通过影响巨细胞,髓状细胞衍生的抑制细胞,树突细胞和淋巴细胞,损害抗瘤免疫力.
- 特定的免疫细胞功能障碍包括抑制T细胞增殖,抗原呈现受损,以及促进调节性T细胞 (Treg) 现型.
结论:
- 准胆固醇代谢是癌症治疗的可行治疗策略.
- 降胆固醇药物可能会增强免疫疗法的有效性,例如免疫检查点阻塞 (ICB).
更多相关视频
相关概念视频
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Cytotoxic T Cells-mediated Immune Response
725
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
725
Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398


